The aim of the accompanying comments is to help clarify the objectives, methods and policy decisions involved in screening young athletes in order to prevent sudden cardiac death (SCD) due to coronary artery anomalies (CAAs). This information is provided as a commentary to the article published in the current issue of the journal by Gerling et al. 1 Coronary artery anomalies are a special issue in sports-related screening. The definitions, anatomofunctional features and treatments for these congenital defects are often vaguely specified. 2, 3 Physicians should consider CAAs not only in terms of how they are anatomical exceptions to the rules (anatomical variants) but, more importantly, in terms of their functional behavior during strenuous exertion at the time of training and/or competing. The clinical manifestations of CAAs are rarely seen in sedentary individuals.
General theory about CAAs
Physicians currently agree on the principle that CAAs are congenital defects that can lead to significant clinical manifestations, mostly due to exertion-related transient myocardial ischemia. 2, 3 Only a few types of CAAs have credible mechanisms for inducing ischemia capable of causing SCD in athletes or military recruits. 2, 3 The best objective evidence of such occurrences comes from a recent large study of military recruits conducted by Eckart et al. 4 The study showed a correlation between episodes of SCD and autopsy evidence of potentially critical ischemia by stenosis. Such events are primarily associated with having a left coronary artery with an anomalous origin from the right sinus of Valsalva and an intramural course (synthetically called L-ACAOS-IM 2 ). As is commonly recognized, no new intrinsic death-related changes in the preexistent congenital coronary defect were reported by Eckart et al., 4 but the L-ACAOS-IM anomaly has been found to be 483 times more prevalent in recruits who died when submitted to extreme exertion for 2 months of exercise training than in control persons. [2] [3] [4] Such a high prevalence of CAAs in the recruits who died is a clear indication of the increased risk associated with specific defects, especially left coronary artery anomalies. The peak age at which SCD occurred was 18.5 years. At later ages, the same defects do not pose as high a risk of SCD. 5 No other CAA poses the same risk as L-ACAOS-IM (not even the sister anomaly R-ACAOS-IM, 3 which is more prevalent in the general population but was not considered responsible for any of the SCDs in the study). No correlation has been found between SCD and CAAs involving a nonintramural course (such as the pre-pulmonic, infundibular, retro-aortic and retro-cardiac courses); furthermore, the risk level varies between individual cases of L-ACAOS-IM and appears to be related to the specific severity of stenosis at rest and with exertion. 2, 3 The specific mechanism of stenosis for L-ACAOS-IM is lateral compression (narrowing of the lumen of the ectopic coronary artery where it crosses from the anomalous to the correct side of the aorta); such narrowing is variable, increasing phasically during systole, but also with tachycardia or higher cardiac output/stroke volume. 2, 3 Some degree of coronary hypoplasia may also be implied in some of these cases. An inter-arterial course 'between the great vessels' is frequently, but erroneously, assumed but never confirmed by precise imaging (such as intravascular ultrasound or surgical exploration) when the course of the ectopic vessel is close to the edge of the anterior commissure. Interestingly, a recent study in military personnel showed that the risk of SCD is not as high in adults with a CAA as it is in youth with a CAA.
Imaging at primary screening evaluation
The large 'Screen to Prevent' (S2P) study recently completed here at the Texas Heart Institute in Houston screened a general population of more than 5000 adolescents by using magnetic resonance imaging (MRI). 5 One focus of the S2P study was to screen for ACAOS-IM and look for evidence of an intramural course. Such studies clearly showed the generalized presence of coronary ostial ectopy and the abnormal location of the proximal artery inside the aortic tunica media at the level of the anterior commissure, but the MRI results could not be used to evaluate the severity of coronary stenosis to characterize the risk level of each individual with an ACAOS-IM anomaly. Currently, there is an ongoing discussion about when to use MRI for screening. The proposal that has been suggested is to do routine MRI screening of high-risk individuals, especially athletes (elite only?) and soldiers. Although computed tomographic angiography could provide more precise results than MRI, MRI screening can identify the specific type of coronary artery anomaly, including the origin and course, without the use of intravenous contrast agents or medications, and it has no ionizing radiation limitations. 7 Usually, MRI is only used at present as a secondary screening test for athletes who had a primary screening test with unclear results. 8 Our conclusion from the S2P study was that similar athletics candidates correctly identified by screening MRI as potentially being at high risk for SCD may need to be evaluated secondarily with intravascular ultrasound (IVUS) imaging if they have symptoms or positive stress test results.
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Using echocardiography to identify CAAs
Echocardiography has recently been used in a few screening studies. 9, 10 This technique is less apt to provide adequate imaging because of its intrinsic lower precision and variable ultrasonographic windows, especially in adults weighing more than 40 kg. In most diagnostic cases of CAAs, color-Doppler interrogation helps with identifying the anomalous coronary course and potential severe stenoses (because of high blood flow velocity); however, such enhancement techniques are difficult to use in the field during screening studies because the technicians usually employed for such functions have limited training in these techniques. Gerling et al. 1 claim to have achieved great accuracy and precision by using 'echocardiography screening' (although they more likely used 'clinical studies' performed by specialist physicians), but unfortunately no gold standard imaging, such as MRI or coronary contrast tomographic angiography, was used for comparison. True false-positive and, especially, false-negative results could not be fully evaluated by using such a protocol. Two prior screening studies of more than 2000 young athletes in Texas and Spain 9,10 yielded quite low prevalence rates of ACAOS (close to zero!) compared to those determined with our recent MRI data (total ACAOS-IM, 0.43%; L-ACAOS-IM, 0.11%; R-ACAOS, 0.32%). 5 Similarly, when searching for 'CAAs of potential hemodynamic significance', Gerling et al. 1 reported identifying only two cases of R-ACAOS-IM (which is likely) and no cases of L-ACAOS-IM (quite less than would be expected according to our MRI data in a similar population). All the other 'coronary abnormalities' listed in Table  2 refer to conditions that would not put an individual at high risk for SCD during sports. 1 
Using patient histories and physical exams to identify CAAs
The S2P study clarified that patients' histories and physical exams are not reliable methods to identify individuals at high risk of structural heart conditions, as eventually demonstrated by MRI. High-precision imaging is required to identify important CAAs; otherwise, they are overlooked in the screening process. Secondary evaluation with stress testing has not been helpful for determining the severity of stenosis; secondary evaluation will depend mostly on IVUS imaging. [2] [3] [4] In most reported cases of SCD in patients with a CAA, the tragic events were related to maximal exertion and were unexpected, despite the completion of traditional screening (history, physical exam and, occasionally, an electrocardiogram). A recent detailed, longitudinal study of adolescent European football (called soccer in USA) players screened with echocardiography found only two cases of ACAOS-IM (one R-ACAOS-IM and one L-ACAOS-IM) in 11,168 young athletes, giving a prevalence of 0.018% (less than half that expected by our MRI data). 11 It is important to add that anomalous aortic origin of the left coronary artery (AAOLCA) includes many more cases (unreported by authors who use this terminology) that do not have an intramural course and are generally benign, as discussed above.
Conclusion
In summary, screening for CAAs of importance for the prevention of SCD in athletes requires sophisticated and updated knowledge about the unusual pathology of these anomalies and the use of delicate techniques tailored to achieve the two sequential aims of screening: (a) to identify the high-risk anomalies; and (b) to identify the high-risk individuals, related to physical exertion.
